US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Chikungunya

Recent news which mentions Chikungunya

Read Why Valneva's Stock Gained 7% Today
Tickers VALN
Tags Trading Ideas Chikungunya Phase 3 Trial
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags Health Care Phase 3 Trial Chikungunya
From Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
Tickers MRNA
Tags Briefs Phase 1 Trial News
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags General Small Cap VALN
From Benzinga